P. L. Mage, B. S. Ferguson, D. Maliniak, K. L Ploense, T. E. Kippin, H. T. Soh
文献索引:10.1038/s41551-017-0070
全文:HTML全文
Current methods of drug dosing rely on physical parameters (such as sex, age and weight) that do not account for genetic and physiological differences among individual patients. These differences can greatly affect how drugs are processed in the body and can result in ineffective underdosing or toxic overdosing. Here, we describe a generalizable closed-loop system consisting of a biosensor, controller and infusion pump, and a model of drug pharmacokinetics that continuously monitors and adjusts the concentration of a given drug in the body. As proof of concept, we demonstrate that the system can maintain the concentration of doxorubicin—a widely used chemotherapy drug—in live rabbits and rats at any desired set point and in real time, while automatically compensating for large pharmacokinetic differences among individual animals and stabilizing dramatic perturbations arising from acute drug–drug interactions. The feedback-loop system opens up the possibility of tightly controlled, patient-specific dosing of chemotherapeutics and other drugs within narrow therapeutic windows.
|
Versatile synthetic alternatives to Matrigel for vascular to...
2017-07-11 [10.1038/s41551-017-0096] |
|
Ageing: Biomarkers get physical
2017-07-11 [10.1038/s41551-017-0102] |
|
Genetic engineering: Lassoing genomic libraries
2017-07-11 [10.1038/s41551-017-0098] |
|
Intraoperative histology: Lightning 3D histopathology
2017-07-11 [10.1038/s41551-017-0101] |
|
Synthetic biology: A probiotic probe for inflammation
2017-07-11 [10.1038/s41551-017-0097] |
首页 |
期刊大全 |
MSDS查询 |
化工产品分类 |
生物活性化合物 |
关于我们 |
免责声明:知识产权问题请联系 service1@chemsrc.com
Copyright © 2024 ChemSrc All Rights Reserved